Amgen Hits Another Emerging Market Target With $700M Turkish Deal
This article was originally published in The Pink Sheet Daily
Executive Summary
Fulfilling its pledge to dramatically expand internationally, Amgen sealed a deal to purchase coveted drugmaker Mustafa Nevzat, gaining a foothold in Turkey. Meanwhile, its pipeline progresses with no clear winners to help cushion the blows to the company’s ESAs.